Company

LaunXP biomedical

Biotechnology Research 10f, Province of, Tw 15 employees

Employees: 15
Contacts: 1
Emails: 1

www.launxp.com LinkedIn

LaunXP biomedical Overview

Headquarters: 10f, Province of, Tw
Website: www.launxp.com
Industry: Biotechnology Research
Employees: 15
Founded: 2015
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About LaunXP biomedical

Our strategies focus on developing NCE (new chemical entities) for anti-cancer and researching a new or better way of patients. Now we have several patents for 505(b)(1) and 505(b)(2). We developed an anti-cancer rapid screen platform by reposition in new indications for FDA-approved drugs, which we obtained 505(b)(2) patents already. These advantages of those 505(b)(2) drugs would be the First-in-class medication in chemotherapy, shortening the development process and saving significant investment. Furthermore, we developed the new formulation for drug delivery system, which called VLPs. The outcome of VLPs would make LaunXP more comprehensive in drug development area.

LaunXP biomedical Contact Details

People in AeroLeads: 4
With contact data: 1
Email contacts: 1; 25.0% coverage

LaunXP biomedical Org Chart

Sample employees and titles

Name	Title	Location	Contact
Pin-Hung Kuo	朗齊生醫 Clinical Research Associate	Taichung City, Taiwan, Province of China	View
Jack Chen	Launxpsales Specialist	Hsinchu Metropolitan Area, Taiwan, Province of China	View
Joanne Lu			View
Yu-Cheng Hsiao	Director at Launxp Biomedical	Taiwan, Province of China	Email